Search by Drug Name or NDC

    NDC 68047-0185-16 NoHist LQ 4; 10 mg/5mL; mg/5mL Details

    NoHist LQ 4; 10 mg/5mL; mg/5mL

    NoHist LQ is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 68047-0185
    Product ID 68047-185_078c8db6-07c8-d252-e063-6294a90a84d6
    Associated GPIs 43993002300940
    GCN Sequence Number 048597
    GCN Sequence Number Description chlorpheniramine/phenylephrine LIQUID 4-10MG/5ML ORAL
    HIC3 Z2N
    HIC3 Description 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 14148
    HICL Sequence Number 000446
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name NoHist LQ
    Proprietary Name Suffix n/a
    Non-Proprietary Name Chlorpheniramine Maleate and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 4; 10
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Larken Laboratories, Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 68047-0185-16 (68047018516)

    NDC Package Code 68047-185-16
    Billing NDC 68047018516
    Package 473 mL in 1 BOTTLE (68047-185-16)
    Marketing Start Date 2011-01-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04063
    Pricing Unit ML
    Effective Date 2021-11-17
    NDC Description NOHIST-LQ LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2022-11-16
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis